openPR Logo
Press release

Roche, AstraZeneca Market Share in North America and Europe PEGylated Drugs Market|Key Players: Pfizer, Amgen, Biogen, Novo Nordisk

02-11-2019 07:30 PM CET | Health & Medicine

Press release from: Global Market Insights Inc.

North America and Europe PEGylated Drugs Market

North America and Europe PEGylated Drugs Market

Global North America and Europe PEGylated Drugs Market set to exceed USD 10.5 billion by 2024; according to a new research report by Global Market Insights.

Increasing R&D investment of biotechnology & pharmaceutical companies to develop enhanced PEGylated drugs for treatment of various chronic diseases along with rising occurrence of chronic ailments in developed regions will propel PEGylated drugs market growth over the forecast period. Major advancements in biologics sector including advances in drug antibody conjugates, and immunotherapies will positively impact market growth.

Moreover, rising incidences of chronic ailments and increasing death rates associated with cancer in Canada will propel industry growth. However, the side-effects associated with pegylated drugs along with drug failure will impede PEGylated drugs market growth over the forecast timeframe.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2511

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Roche
• AstraZeneca
• Pfizer
• Amgen
• Biogen
• Novo Nordisk
• UCB
• Merck KGaA

Cancer segment held over 60% of the overall market share in 2017 due to growing prevalence of the disease creating a demand for the development of effective drugs. Benefits offered by PEGylated drugs such as reduced proteolytic degradation along with minimized immunogenicity leading to enhanced therapeutic efficacy will propel market growth. Increasing areas of applications as well as rising adoption of PEGylated drugs to treat various types of cancer will stimulate business growth. Hepatitis segment size was USD 156 million in 2017 and is anticipated to follow a declining trend over the forecast period. However, increasing focus of industry players to develop pegylated drugs used for the treatment of such chronic conditions will contribute to market growth. For instance, launch of Pegasys drug used for treating Hepatitis C in adult patients will fuel market growth.

To understand the implications of the cancer segment in defining the North America and Europe PEGylated drugs market, in 2015 about 1.3 million or 26% of all deaths in Europe resulted from cancer, making it the second biggest cause of fatalities in the EU. The upsurge in cigarette smoking and pollution along with unhealthy dietary consumption among EU population is expected to increase the frequency cancer and other chronic diseases. Consequently, the advantages of PEGylated drugs in improving treatments has inspired a number of companies in the region to develop bio-conjugated drugs, strengthening the North America and Europe PEGylated drugs industry.

Elaborating on the significance of North America and Europe PEGylated drugs market, a slew of PEGylated drug delivery systems such as Neulasta, Onivyde and PEG intron are employed in various cancer treatments, with additional drugs in the pipeline or pending approvals. For instance, the U.S. Food and Drug Administration (FDA) accepted a biologics license application from Shire PLC, a biotech leader in rare diseases, for Calaspargase Pegol (Cal-PEG) as a component of antineoplastic combination therapy for acute lymphoblastic leukemia (ALL) patients. The development is based on Shire’s research and experience with ONCASPAR (pegaspargase), a first-line treatment for ALL approved in the U.S. According to reports on the efficiency and safety of Cal-PEG, if approved it will permit availability of treatments that have a prolonged shelf life beyond the current PEGylated asparaginase treatment.

The advent of PEGylation to increase the power and life of drug induced therapies can be justified by explaining the impact of acute lymphoblastic leukemia (ALL). ALL is technically a cancer of the white blood cells, which leads to excess lymphoblasts in the blood, bone marrow and other locations in the body. The American Cancer Society estimates that the risk of developing the disease is highest among children below 5 years of age, which declines gradually by the mid-20s and then arises again after the age of 50. Further, ALL accounts for close to 75% of the overall leukemia cases in U.S. children and up to 78% for the children in Europe. As such, the obligation to produce potent medicines for combination therapeutic treatments has driven the North America and Europe PEGylated drugs industry.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2511

North America & Europe PEGylated Drugs Market by Disease Indication
o Cancer
o Hepatitis
o Multiple sclerosis
o Gastrointestinal disorders
North America & Europe PEGylated Drugs Market by Type
o Monoclonal antibodies (mAbs)
o Colony stimulating factors
o Interferons

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Roche, AstraZeneca Market Share in North America and Europe PEGylated Drugs Market|Key Players: Pfizer, Amgen, Biogen, Novo Nordisk here

News-ID: 1578209 • Views: 192

More Releases from Global Market Insights Inc.

How Steel Rebar Market Going Rapidly…? ArcelorMittal, Acerinox, Essar Steel, T …
Steel Rebar Market research report added by Global Market Insights provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Owing to its massive deployment across numerous noteworthy business verticals along the likes of automotive, manufacturing,
Comprehensive Analysis on Luxury Plumbing Fixtures Market 2019 -2024 | Cera Sani …
Luxury Plumbing Fixtures Market research report added by Global Market Insights provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Luxury plumbing fixtures market is fast emerging to become a niche industry that is incorporating
How Plastic Fencing Market Going Rapidly…? Top players are Tenax, CertainTeed, …
Plastic Fencing Market research report added by Global Market Insights provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Plastic fencing market has been exhibiting a remarkable growth since the last few years pertaining to
How Stone Crushing Equipment Market Growing Rapidly…? Top Key Players Astec In …
Global Stone Crushing Equipment Market Report contains historic data that spans 2019 to 2025, and then continues to forecast to 2025. That makes this report so invaluable, resources, for the leaders as well as the new entrants in the Industry Research details developments in the Report with Detailed Analysis of Key Companies Capacity, Production, Revenue, Price and Gross Margin. Globally rising urbanization trends are also responsible for augmenting stone crushing equipment

All 5 Releases


More Releases for PEG

Global Activated Polyethylene Glycol (PEG) Market Expected to Recover during the …
The global market status for Activated Polyethylene Glycol is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Activated Polyethylene Glycol (PEG) Market Insights, Forecast to 2025”, which tends to deliver in-depth knowledge associated to the Activated Polyethylene Glycol market for the present and forecasted period until 2025. Furthermore, the report examines the target market based
PEG-10 Lanolin Market Swot Analysis 2018 Industry Research 2023
Future Market Reports on Global PEG-10 Lanolin 2018 Research Report presents a professional and complete analysis of Global PEG-10 Lanolin Market on the current market situation. The Global PEG-10 Lanolin Market 2018 report includes PEG-10 Lanolin market Revenue, market Share, PEG-10 Lanolin industry volume, market Trends, Growth aspects. It analyses the important factors of the PEG-10 Lanolin market based on present industry situations, PEG-10 Lanolin market demands, business strategies utilized
Global Children Bike Market 2018-2025 Hasbro, Mattel, Peg Prego, Funtastic
A market study "Global Children Bike Market" examines the performance of the Children Bike market 2018. It encloses an in-depth Research of the Children Bike market state and the competitive landscape globally. This report analyzes the potential of Children Bike market in the present and the future prospects from various angles in detail. The Global Children Bike Market 2018 report includes Children Bike market Revenue, market Share, Children Bike industry volume,
Global Baby Stroller Market 2017 - Emmaljunga, UPPAbaby, Peg Perego, Seebaby
Global Baby Stroller Market 2017 Survival Strategies explore Economic Impact in International Industries Manufactures, Growth, Size, Share, Trends, Development Challenges and Opportunities till 2022 Global Baby Stroller Market 2017-2022 research report by QY Research provides an essential information and statistically evaluated data about the Baby Stroller . The MRS Research Group report provides a detailed study of the Baby Stroller market, enlightening the major areas such as future market scenario, market
Solar Wafer Cutting Fluid PEG Market - Business Development, Growth and Segment …
QY Research Groups’ expert research analysts estimate the Solar Wafer Cutting Fluid PEG Market to grow at a substantial Compound Annual Growth Rate (CAGR) throughout the forecast period 2017 to 2022. The Global Solar Wafer Cutting Fluid PEG Market Research Report 2017 renders deep perception of the key regional market status of the Solar Wafer Cutting Fluid PEG Industry on a global level that primarily aims the core regions which
PEG and PPG Esters Market Globally Expected to Drive Growth through 2026
PEG and PPG Esters Market: Introduction Polyethylene glycol esters are the products of a fatty acid or fatty alcohol and polyethylene glycol. Whereas, polypropylene glycol esters are the combination of propylene glycol mono and diesters of saturated and unsaturated fatty acids which are derived from fats and edible oils. The feedstock required in the production of PEG and PPG esters include edible oils such as palm oil and sunflower oil among